Plasma membrane profiling defines an expanded class of cell surface proteins selectively targeted for degradation by HCMV US2 in cooperation with UL141 by Hsu, Jye-Lin et al.
RESEARCH ARTICLE
Plasma Membrane Profiling Defines an
Expanded Class of Cell Surface Proteins
Selectively Targeted for Degradation by
HCMV US2 in Cooperation with UL141
Jye-Lin Hsu1☯¤, Dick J. H. van den Boomen1☯, Peter Tomasec2☯, Michael P. Weekes1☯,
Robin Antrobus1, Richard J. Stanton2, Eva Ruckova3, Daniel Sugrue2, Gavin S. Wilkie4,
Andrew J. Davison4, Gavin W. G. Wilkinson2, Paul J. Lehner1*
1 Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom,
2 School of Medicine, Cardiff University, Cardiff, United Kingdom, 3 Regional Centre for Applied Molecular
Oncology (RECAMO), Masaryk Memorial Cancer Institute, Brno, Czech Republic, 4 MRC-University of
Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom
☯ These authors contributed equally to this work.
¤ Current address: Research Center for Tumor Medical Science, China Medical University, Taichung,
Taiwan
* pjl30@cam.ac.uk
Abstract
Human cytomegalovirus (HCMV) US2, US3, US6 and US11 act in concert to prevent im-
mune recognition of virally infected cells by CD8+ T-lymphocytes through downregulation
of MHC class I molecules (MHC-I). Here we show that US2 function goes far beyond MHC-I
degradation. A systematic proteomic study using Plasma Membrane Profiling revealed US2
was unique in downregulating additional cellular targets, including: five distinct integrin α-
chains, CD112, the interleukin-12 receptor, PTPRJ and thrombomodulin. US2 recruited the
cellular E3 ligase TRC8 to direct the proteasomal degradation of all its targets, reminiscent
of its degradation of MHC-I. Whereas integrin α-chains were selectively degraded, their
integrin β1 binding partner accumulated in the ER. Consequently integrin signaling, cell ad-
hesion and migration were strongly suppressed. US2 was necessary and sufficient for deg-
radation of the majority of its substrates, but remarkably, the HCMV NK cell evasion
function UL141 requisitioned US2 to enhance downregulation of the NK cell ligand CD112.
UL141 retained CD112 in the ER from where US2 promoted its TRC8-dependent retrotran-
slocation and degradation. These findings redefine US2 as a multifunctional degradation
hub which, through recruitment of the cellular E3 ligase TRC8, modulates diverse immune
pathways involved in antigen presentation, NK cell activation, migration and coagulation;
and highlight US2’s impact on HCMV pathogenesis.
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Author Summary
As the largest human herpesvirus, HCMV is a paradigm of viral immune evasion and has
evolved multiple mechanisms to evade immune detection and enable survival. The
HCMV genes US2, US3, US6 and US11 promote virus persistence by their ability to down-
regulate cell surface MHC. We developed ‘Plasma Membrane Profiling’ (PMP), an unbi-
ased SILAC-based proteomics technique to ask whether MHCmolecules are the only
focus of these genes, or whether additional cellular immunoreceptors are also targeted.
PMP compares the relative abundance of cell surface receptors between control and viral
gene expressing cells. We found that whereas US3, US6 and US11 were remarkably MHC
specific, US2 modulated expression of a wide variety of cell surface immunoreceptors.
US2-mediated proteasomal degradation of integrin α-chains blocked integrin signaling
and suppressed cell adhesion and migration. All US2 substrates were degraded via the cel-
lular E3 ligase TRC8, and in a remarkable example of cooperativity between HCMV im-
mune-evasins, UL141 requisitioned US2 to target the NK cell ligand CD112 for
proteasomal degradation. HCMV US2 and UL141 are therefore modulators of multiple
immune-related pathways and act as a multifunctional degradation hub that inhibits the
migration, immune recognition and killing of HCMV-infected cells.
Introduction
HCMV is the prototype betaherpesvirus and an important human pathogen. Following prima-
ry infection, HCMV persists for the lifetime of the host under constant control by the host im-
mune system. In the face of this selective pressure, HCMV has evolved multiple mechanisms to
evade immune detection and has emerged as a paradigm of viral immune modulation and eva-
sion. Experimentally, only 45 of the ~170 canonical HCMV protein coding genes are required
for in vitro replication [1, 2]; most HCMV genes appear to be directed at promoting virus per-
sistence through targeting host defenses [3–5].
Four genes clustered in the HCMV unique short (US) gene region use independent mecha-
nisms to suppress MHC-I dependent antigen presentation to CD8+ cytotoxic T lymphocytes
[6]. US3 is an immediate early gene product that binds and retains newly synthesized MHC-I
proteins in the endoplasmic reticulum (ER) and blocks tapasin-dependent peptide loading [7,
8], whereas US6 inhibits TAP-mediated peptide translocation into the ER [9, 10]. US2 and
US11 both bind MHC-I in the lumen of the ER and hijack the mammalian ER-associated deg-
radation (ERAD) machinery to promote retrotranslocation to the cytosol for proteasome deg-
radation [11, 12]. US2 and US11 appropriate distinct cellular ERAD pathways for MHC I
dislocation. US2 utilizes the cellular E3 ligase TRC8 (translocation in renal cancer from chro-
mosome 8) to ubiquitinate and subsequently degrade MHC-I [13], whereas US11 uses a Der-
lin-1-associated ERAD complex centered around the newly characterized TMEM129 E3 ligase
[14–16]. Functionally US2 and US11 are distinct as US11 has a combined ER retention and
degradation function [13, 15, 17], while US2 is unable to retain MHC-I in the ER prior to deg-
radation, but relies on US3 for enhanced degradation. In addition to downregulating MHC-I,
US2 and US3 also target the MHC-II antigen presentation pathway [18, 19]. US3 retains
MHC-II molecules in the ER while US2 initiates the retrotranslocation of MHC-II DR-α chain
and DM-α chain from the ER back to the cytosol for subsequent degradation.
Since endogenous MHC-I molecules constitute the chief ligands recognized by NK cell in-
hibitory receptors, their downregulation has the potential to render cells more vulnerable to
NK cell attack. To compensate, HCMV encodes its own MHC-I homologue (UL18) and a
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peptide present in the UL40 signal sequence acts to stabilize and maintain cell surface expres-
sion of the NK inhibitory ligand HLA-E [20–24]. Moreover, HCMV systematically suppresses
cell surface expression of ligands for NK cell activating receptors. The HCMV glycoprotein
UL141 plays a major role in such protection via interaction with TRAIL death receptors, as
well as CD155 (PVR, necl5) and CD112 (PVRL2, nectin-2) which are both ligands for the ubiq-
uitous NK activating receptor DNAM1 [25–27]. In isolation, UL141 is capable of suppressing
both CD155 and TRAIL-R2 cell surface expression, but an additional HCMV-encoded factor
is known to be required for efficient downregulation of cell surface CD112 [25]. Moreover,
while CD155 and TRAIL-R2 accumulate in the ER during the course of infection, CD112 is de-
graded [25].
While US2, US3, US6 and US11 were originally defined by their capacity to inhibit cell sur-
face MHC-I expression, classical MHCmolecules are not necessarily their only targets. To gain
an unbiased view of cellular receptors whose expression is altered upon viral gene expression, we
recently developed ‘PlasmaMembrane Profiling’ (PMP), a SILAC (Stable Isotope Labelling of
Amino acids in Culture)-based quantitative proteomics technique which compares the relative
abundance of cell surface receptors between infected and uninfected cells, and therefore identi-
fies the range of cell surface proteins downregulated upon viral infection [28–30]. PMP demon-
strated that whereas US3, US6 and US11 specifically downregulate MHC-I, US2 targets a series
of novel substrates including the NK cell ligand CD112, the anti-coagulation factor thrombomo-
dulin and at least six integrin family members, abolishing integrin signalling, cell adhesion and
migration. While US2 alone is necessary and sufficient to target most substrates, effective down-
regulation of CD112 requires a synergistic interaction between US2 and UL141. UL141 retains
CD112 in the ER and associates with US2 resulting in CD112 dislocation across the ER mem-
brane for proteasome degradation. We therefore propose a role for US2 that is much broader
than previously appreciated, but nevertheless depends on the common activity of TRC8 for im-
pact. Furthermore, US2 and UL141 form a multifunctional and highly adaptive degradation hub
with a substrate range much wider than previously appreciated, affecting cellular processes as
broad as antigen presentation, NK cell killing, cell migration and coagulation.
Results
Plasma membrane profiling identifies novel HCMV US2 specific
substrates
To determine whether the HCMV-encoded US2, 3, 6 and 11 viral gene products downregulate
cell surface proteins in addition to MHCmolecules, we used Plasma Membrane Profiling
(PMP), an unbiased, proteomic technique which compares the relative abundance of plasma
membrane proteins [28]. Plasma membrane proteins were isolated from THP-1 monocytic
cells stably expressing HCMV US2, US3, US6 or US11 by sequential cell surface glycoprotein
biotinylation followed by streptavidin pull-down and their relative expression was quantified
by high through-put mass spectrometry. To minimise differences in sample preparation, cells
were metabolically labelled prior to biotinylation by SILAC, which allows early stage sample
mixing without loss of sample identity [31]. The relative abundance of plasma membrane pro-
teins in US2, US3, US6 or US11 expressing cells versus control is plotted in Fig 1A with indi-
vidual proteins represented by single dots. Those proteins whose expression is unaltered by
viral gene expression accumulate in the centre, whereas left and right shifts represent proteins
down- or up-regulated at the plasma membrane of viral gene expressing cells.
In US3, US6 and US11 expressing cells, the majority of plasma membrane proteins identi-
fied (370–454) were unchanged, with HLA-A, B and C allotypes of MHC-I molecules being the
predominant proteins lost from the cell surface (Fig 1A; left and top right panels). US3 also
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showed a decrease in MHC-II and C1q complement receptor expression. In contrast, US2 al-
tered the expression of a multitude of cell surface receptors, with thirteen new proteins showing
more than a four-fold downregulation (Fig 1A bottom right panel, S1 Table). In addition to
MHC-I, six integrin family members were downregulated: α1 (ITGA1, 4.9 fold), α2 (ITGA2,
Fig 1. Identification of novel US2 specific substrates by plasmamembrane profiling.US2 downregulates cell surface expression of α and β integrins in
addition to other proteins. (A) Scatter plots of proteins identified in PMP and quantified by 2 or more unique peptides. Fold change (single gene expressing
THP-1 cells / control THP-1 cells) is shown as log2 ratio on the x axis and the summed peptide intensity on the y-axis as log10. Proteins unaltered by viral
gene expression locate to the center of the plots (0-fold change), whereas proteins left or right of center represent respectively proteins down- or up-regulated
by viral gene expression. Significance B was used to estimate p values. (B) Verification of integrin downregulation in US2-expressing THP-1.
Cytofluorometric analysis of the indicated proteins in THP-1 cells stably expressing US2 with or without TRC8 depletion, and control THP-1 cells. (C)
Representation of the integrin family. Integrins downregulated by US2 are highlighted in red. See also S1 and S2 Figs and S1 Table.
doi:10.1371/journal.ppat.1004811.g001
HCMVUS2 Regulates Multiple Cell Surface Proteins
PLOS Pathogens | DOI:10.1371/journal.ppat.1004811 April 14, 2015 4 / 24
10.7 fold), α4 (ITGA4, 15.3 fold), α5 (ITGA5, 3.9 fold), α7 (ITGA7, 4.3 fold) and β1 (ITGB1,
5.2 fold). Other substrates downregulated by US2 include thrombomodulin (THBD, 31.9 fold),
protein tyrosine phosphatase, receptor type, J (PTPRJ, 4.9 fold) and the interleukin-12 receptor
β1 (IL12RB1, 8.9 fold).
US2 substrates are downregulated in a TRC8-dependent pathway
We focused on novel US2 substrates and confirmed their downregulation by flow cytometry.
Indeed US2 expressing THP-1 cells showed a robust downregulation of integrins α1, α2, α4,
β1, thrombomodulin, PTPRJ and IL12 receptor β1 (Fig 1B, grey line), compared to control
(black line). Other cell surface molecules, including the transferrin receptor and integrin αV,
remained unaffected by US2 and none of the US2 substrates were affected by US11 expression
(S1 Fig), thus confirming the specificity of substrate down-regulation. AXL, integrin αM
(ITGAM) and αL (ITGAL) expression was dysregulated by lentiviral transduction and not
followed further.
US2 is a type I membrane protein that co-opts the cellular ERAD degradation machinery to
degrade MHC-I [12]. The ER-resident ubiquitin E3 ligase TRC8 is a critical component of the
US2-mediated MHC-I degradation pathway [13]. US2 recruitment of TRC8 is required for the
ubiquitination and subsequent degradation of newly synthesized MHC-I, and in the absence of
this ligase MHC-I is rescued back to the cell surface [13]. In a similar manner, shRNA knock-
down of TRC8 in US2-expressing THP-1 cells rescued cell surface expression of integrins,
THBD, PTPRJ and IL-12Rβ1 (Figs 1B dashed line and S2). The recruitment of TRC8 thus ap-
pears to be a common and essential step in the US2 pathway.
US2 induces proteasomal degradation of integrin -chains and secondary
accumulation of an immature integrin β1 in the ER
To further examine the fate of these novel US2 substrates, we focused first on the integrin fami-
ly. Integrins consist of an / chain heterodimer. All integrin alpha chains downregulated by US2
share the common beta-1 chain as their binding partner (Fig 1C). Integrins require α/β dimeri-
sation prior to transport to the cell surface and loss of either may result in ER retention of the
other subunit. It was therefore important to test whether the various α subunits or the β1 chain
itself constitute the primary US2 substrate. On immunoblots integrin 4, 5 and 6 expression was
strongly decreased in US2-expressing THP-1 cells (Figs 2A lane 3 and S3), suggesting not only
down-regulation from the cell surface but US2-dependent degradation. Indeed integrin expres-
sion was rescued by proteasome inhibition (Fig 2B lane 7) or shRNA-mediated depletion of
the TRC8 E3 ligase (Fig 2A and 2B lane 4). US11-expressing cells showed no change in integ-
rin expression (Fig 2A and 2B lane 2). Unexpectedly, the integrin 1 chain was not itself de-
graded in US2-expressing cells, but accumulated in its faster migrating ER-resident immature
form (Fig 2A lane 3). TRC8 depletion rescued this immature species to its mature form, while
expression of the control integrin 3 was unaffected by US2 (Fig 2A lanes 3 and 4).
We used [35S]-methionine radiolabeling and pulse-chase analysis to further examine how
US2 affects 4 and 1 integrin maturation. Integrin 4 was rapidly degraded in US2-expressing
cells with a marked reduction in its half-life from more than 1 hour to less than 15 minutes
(Fig 2C), which was prevented by the use of proteasome inhibitors (Fig 2D). In contrast, in the
presence of US2, the 1 integrin was neither degraded, nor was it able to mature to its higher
molecular species but remained in the ER in its immature form throughout the course of the 3
hour chase (Fig 2E). Our data suggest that α integrins are direct substrates for the US2/TRC8
pathway of proteasomal degradation, whereas ER retention of the β1 integrin is likely second-
ary to degradation of its α integrin interaction partners.
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The luminal domain of US2 binds integrin alpha4 and the US2
cytoplasmic tail is essential for recruiting the TRC8 E3 ligase for
substrate degradation
US2 rapidly degrades its target proteins, making it difficult to ascertain whether they physically
interact with US2. A truncated US2 mutant (US2ΔC'), from which the cytoplasmic tail was
Fig 2. US2 induces the proteasomal degradation of integrin α4 and α5 and prevents maturation of the β1 integrin. (A and B) US2 induces
proteasomal degradation of integrins α4 and α5. THP-1 cells stably expressing US2, US11 or depleted of TRC8 (shTRC8) were analyzed by immunoblots for
the indicated proteins. Cells were treated with the proteasome inhibitor lactacystin for 18 hours before harvest as indicated. (C-D) Integrin 4 is proteasomally
degraded in US2-expressing cells. THP-1 cells expressing integrin α4-HA were labeled with [35S]methionine-cysteine and pulse-chased for the indicated
times in the presence or absence of MG132, followed by integrin α4 immunoprecipitation using the HA-tag (E) β1 integrin accumulates in its precursor form in
the presence of US2. THP-1 cells were pulse-chase labelled as above and endogenous β1 integrin was immune precipitated using anti-integrin β1 antibody.
(F and G) US2 associates with integrin α4 and recruits the TRC8 E3 ligase via its cytosolic tail. Cells stably expressing full-length US2 (US2) or US2 with
Δ186–199 residues (US2ΔC') in combination with TRC8-HA or integrin α4-HA were solubilised in 1% digitonin, immunoprecipitated with anti-HA antibody
and visualized by immunoblot. (H) US2 induces integrin α4 ubiquitination. THP-1 cells expressing integrin α4-HA in combination with US2 or empty vector
were pulse-chase labeled for the indicated times. Integrin α4 was immune precipitated using the HA-epitope tag, eluted from beads, fully denatured to
dissociated non-covalently linked proteins and re-precipitated using α-HA or α-ubiquitin antibodies.
doi:10.1371/journal.ppat.1004811.g002
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deleted (aa 186–199) is reported to be functionally inactive, but can still bind its MHC-I sub-
strate [32], providing a useful tool to probe US2 interactions. We initially tested whether the
US2 cytosolic domain is responsible for TRC8 recruitment, which would explain the US2ΔC'
loss of function. While wild-type US2 readily binds TRC8 [13], this association is lost in the
US2ΔC' mutant (Fig 2F lanes 5 and 6), explaining the loss of function phenotype. Further-
more, the US2ΔC' mutant is now found associated with, but unable to degrade integrin α4
(Fig 2G lanes 3 and 6), suggesting that US2 binds its α integrin substrate prior to recruitment
of TRC8.
Ubiquitination by TRC8 triggers the US2-induced retrotranslocation and degradation of
MHC-I [13]. We therefore examined whether integrin α4 is also ubiquitinated in the presence
of US2. Immune precipitation of radiolabelled integrin α4 visualized a smear of ubiquitinated
species in the presence but not absence of US2 (Fig 2H). These species were recovered upon
denaturation and re-precipitation of integrin α4 as well as ubiquitin. Integrin α4 is thus ubiqui-
tinated in a US2-dependent manner triggering its proteasomal degradation.
US2-mediated integrin degradation inhibits downstream integrin
signalling, cell adhesion and migration
To address the functional consequence of US2-mediated integrin downregulation, we focused
on the signaling properties of the most dramatically down-regulated integrin, α4β1. The im-
portance of the α4β1 integrin in embryogenesis and disease pathogenesis derives from its role
in cell adhesion and cell migration [33, 34]. Binding of integrin α4β1 to its ligands fibronectin
or vascular cell adhesion molecule-1 (VCAM-1) initiates focal adhesion complex assembly and
phosphorylation of paxillin [35, 36]. This phosphorylation event is specific to integrin β1 and
α4 tails, and is not stimulated by other α-integrins [33–35]. Fibronectin stimulation of vector-
only and US11-transduced control cells led to the expected increase in paxillin phosphoryla-
tion (Fig 3A, top panel, lanes 5 and 7), while US2 inhibited phosphorylation of paxillin as
effectively as shRNA-induced depletion of the β1 integrin (lanes 6 and 8). Since the α4β1
integrin is required for macrophage chemotaxis, we examined how US2 affects cell adhesion
and migration. Adhesion of US2-expressing THP-1 cells to a fibronectin substrate was
completely abolished (Fig 3B) and migration of these cells was significantly reduced (Fig 3C)
compared to the empty vector and US11 controls. A similar phenotype was observed in β1
integrin depleted cells. Thus US2-induced downregulation of integrin α4β1 has dramatic func-
tional consequences, inhibiting downstream integrin-mediated signalling, cell adhesion and
migration.
US2 modulates cellular gene expression in productive HCMV infection
US2 expression alone is both necessary and sufficient for downregulation and TRC8-depen-
dent degradation of the novel substrates. We next sought to investigate US2 function in the
context of a productive HCMV infection and, in an experiment complementary to US2 single
gene expression, evaluated the effect of deleting US2 from the HCMV genome using PMP. Per-
missive human foreskin fibroblasts (HFF) were infected with the HCMV strain Merlin
(HCMV wt) or a US2 deletion virus (HCMV ΔUS2), SILAC labeled and plasma membrane
proteins were isolated and quantified. Proteins whose relative abundance is higher in cells in-
fected with HCMV ΔUS2 compared to those infected with wt-HCMV require US2 for their
downregulation (left shift in Fig 4A). Of 686 plasma membrane proteins identified from
HCMV-infected HFFs, four integrin family members (α2 (3.6 fold), α4 (3.2 fold), α6 (7.7 fold),
and β4 (6.4 fold) (Fig 4A and S2 and S3 Tables) as well as PTPRJ were significantly downregu-
lated in a US2-dependent manner. In addition, other immunoglobulin superfamily members
HCMVUS2 Regulates Multiple Cell Surface Proteins
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that had not been identified in THP-1 cells also required US2 for their downregulation. These
included immunoglobulin superfamily member 8 (IGSF8) and epithelial cell adhesion mole-
cule (EPCAM) as well as butyrophilin subfamily 2 member A1 (BTN2A1), cadherin-4 (CDH4)
and endothelin-converting enzyme 1 (ECE1) (Fig 4A and S3 Table). To validate PMP results,
flow cytometry was performed on HFFs infected with either an HCMV variant encoding a
UL32-GFP fusion protein or the same virus additionally deleted for the US1-11 region. Gating
on GFP+ HCMV-infected cells confirmed that the US1-11 region was required to downregu-
late MHC-I, integrin α4 and THBD (Fig 4B). In a further test with the specific HCMV ΔUS2
mutant used for PMP, infected cells were distinguished by their downregulation of MHC-I.
MHC-I downregulation is unaffected with the HCMV ΔUS2 mutant due to redundancy with
the US3/6/11 gene products (S2 Table). By gating on MHC-Ilo HCMV-infected cells we con-
firmed that downregulation of integrin α4 and THBD was specifically dependent on US2
(Fig 4C). Thus, we confirmed that many of the key US2 targets in THP-1 cells were also down-
regulated in HFFs in the context of HCMV infection.
US2 decreases integrin-mediated cell adhesion of differentiated THP-1
cells during lytic HCMV infection
HCMV infected myeloid cells are thought to play a key role in the spreading of virus in vivo.
Effective mechanisms of immune evasion will be important for enabling viral reactivation in
the presence of a primed immune system. We therefore tested whether the US2-induced sub-
strate downregulation observed in whole HCMV-infected HFFs could be replicated in
Fig 3. US2-mediated downregulation of integrins inhibits downstream integrin-mediated signalling, cell adhesion andmigration. (A) US2 inhibits
signaling downstream of integrin α4β1. THP-1 cells were seeded on tissue culture plates coated +/- fibronectin as indicated for 1 hour at 37°C. Total cell
lysates of adherent and non-adherent cells were analyzed by immunoblotting with phospho-specific antibody to tyr118 paxillin and total paxillin. (B) US2
inhibits THP-1 cell adhesion. THP-1 cells were seeded in triplicate on tissue culture plates coated with fibronectin as indicated for 1 hour at 37°C and washed
3 times with PBS. Adherent cells were quantified by CyQUANT-NF (Invitrogen). The percent adherent cells was normalized against control cells expressing
empty vector (vector/US2 n = 3; US11/shbeta1 n = 2). (C) US2 inhibits cell migration. THP-1 cell migration +/- chemotaxis agent MCP-1 (10 nM) was
examined in cells stably expressing US2, US11, control or ITGB1 shRNA (shbeta1) using fibronectin-coated Transwell plates. Number of cells migrated to
the lower compartment is indicated (average of triplicates, n = 4). Data are represented as mean ± SEM. p-values were calculated using paired Student’s t-
test.
doi:10.1371/journal.ppat.1004811.g003
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differentiated THP-1 cells, and specifically how US2-induced integrin downregulation affects
cell adhesion. PMA-activated THP-1 cells were infected with the endothelial-tropic HCMV
strain TB40 harboring a UL32-GFP marker [37]. Since a ΔUS2 mutant of this strain was not
available, we inactivated US2 function by a stable TRC8 knockdown, prior to TB40 infection.
Comparing control to TRC8 knock-down, we observe a striking US2/TRC8-dependent down-
regulation (Fig 5A) and degradation (Fig 5B lanes 3 and 4) of integrins α2, α4, α6 and throm-
bomodulin in HCMV-infected cells. This downregulation is therefore similar to that observed
following HFF infection with the HCMVMerlin strain (Fig 4A, 4B, and 4C). Integrin α6,
which is not detected in basal THP-1 cells (Fig 5B lanes 1 and 2), was markedly induced upon
viral infection and concomitantly downregulated via the US2/TRC8 pathway (Fig 5B lanes 3
and 4), suggesting a potent anti-viral role counteracted by US2. A similar upregulation upon
virus infection and subsequent downregulation by US2 was observed for thrombomodulin in
HFF cells (Fig 4B).
To assess the functional consequence of US2-induced integrin downregulation in HCMV
infected cells, TB40-infected THP-1 cells were allowed to adhere to fibronectin, recombinant
VCAM-1, collagen or uncoated tissue culture wells. TB40-infected THP-1 cells with a control
knock-down showed significantly decreased binding to both VCAM-1 and collagen, but not
uncoated wells, compared to TRC8 knock-down cells (Fig 5C). VCAM-1 and collagen are
Fig 4. PMP comparing wild-type and US2-deficient HCMV shows a requirement for US2 in the downregulation of cell surface targets. (A) Scatter
plots of proteins identified in PMP and quantified by 2 or more unique peptides. Fold change (HFF infected with wild-type HCMV versus HFF infected with
ΔUS2 HCMV) is shown as log2 ratio on the x axis and the summed peptide intensity on the y-axis as log10. Proteins unaltered by HCMV US2 gene deletion
locate to the center of the plots (0-fold change), whereas proteins left or right of center represent respectively proteins down- or up-regulated by HCMV in a
US2-dependent manner. Significance B was used to estimate p values. (B) US2 is required for integrin and thrombomodulin downregulation during HCMV
infection. HFF cells infected with GFP tagged HCMV ΔUL16-18 or ΔUL16-18ΔUS1-11 (moi 0.5) were analyzed by cytofluorometric analysis of the indicated
proteins at 72 hours post-infection. (C) HFFs infected with HCMV wild-type or ΔUS2 (moi 0.5) were analyzed by flow cytometry at 72 hours post-infection.
Cell surface staining for MHC-I enabled gating for HCMV infected (MHC-Ilo) cells (left panel) and subsequent analysis of the integrin and thrombomodulin
expression (right panels). See also S3 Table.
doi:10.1371/journal.ppat.1004811.g004
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respectively substrates for the US2-targetted integrins α4 and α2. Binding to fibronectin—a
less specific substrate for integrin α4—was unaffected by TRC8 knock-down. This lack of an ef-
fect is likely due to up-regulation of integrin αV in PMA-activated THP-1 cells; this β3-associ-
ated integrin binds readily to fibronectin but is not a US2 substrate. In conclusion we show α
integrins including α2, α4 and α6 are specific US2 substrates that are degraded in a TRC8-de-
pendent manner upon both US2 single gene expression and whole HCMV infection, thereby
reducing cell adhesion of myeloid cells to a variety of substrates.
US2 and UL141 co-operate to downregulate the NK cell ligand CD112
HCMVUL141 is a powerful NK cell evasion gene that downregulates NK cell ligands CD112,
CD155 and the death receptor TRAIL-R2 from the cell surface [25, 26, 38]. Our previous data in-
dicated that UL141 requires an additional unmapped HCMV function to efficiently downregu-
late CD112 [25]. The PMP study revealed that US2 was also able to alter CD112 expression,
both independently and in the context of HCMV infection (Figs 1A and 4A and S1 Table), so
we further analyzed and compared specific UL141 and US2 deletion mutants. Proteomic analysis
of HFF cells infected with a HCMVUL141 deletion mutant versus wild-type HCMV confirmed
UL141-dependent down-regulation of the known UL141 targets: CD155, TRAIL-R2 and
CD112. TRAILR4 was identified as a novel UL141 target (Fig 6A). While expression of the US2
gene alone caused only a modest downregulation of CD112 (2.4 fold) (Fig 1A and S1 Table), in
the context of whole virus infection, the observed robust CD112 downregulation was clearly de-
pendent on both US2 and UL141 (Figs 4A and 6A and S3 Table). A further PMP experiment
using a dual ΔUS2ΔUL141 HCMV deletion mutant (Fig 6B and S3 Table) confirmed many of
the changes we observed using single gene deletion viruses, and showed that CD112 downregula-
tion was most efficient in the presence of both viral genes (Fig 6A, 6B, and 6C; S3 Table). These
results suggest a requirement for both US2 and UL141 for effective CD112 downregulation.
Fig 5. US2/TRC8-mediated degradation of α integrins reduces cell adhesion of lytically HCMV infected THP-1 cells. (A,B) TRC8 depletion abolishes
US2-induced α integrin degradation in HCMV infected THP-1 cells. THP-1 cells stably expressing a control shRNA (shCtrl) or shRNA targeting TRC8
(shTRC8) were PMA activated and infected with HCMV TB40 UL32-GFP (moi 25). Expression of indicated integrins was assessed at 96 hours post-infection
by flow cytometry (A) or immunoblotting (B). (C) TRC8/US2-mediated degradation of α integrins reduces cell adhesion of HCMV-infected THP-1 cells. THP-1
cells were infected as above and at 96 hours post-infection counted, and seeded on tissue culture plates coated with fibronectin, recombinant VCAM-1-Fc,
collagen or uncoated. After a 1 hour (fibronectin, VCAM-1, uncoated; n = 4) or 2 hours (collagen n = 2) incubation, loosely attached cells were washed off and
the number of adherent cells was determined by CyQUANT-NF assay. Data show adhesion relative to fibronectin binding of control cells as mean ± SEM. p-
values were calculated using paired Student’s t-test.
doi:10.1371/journal.ppat.1004811.g005
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UL141 retains CD112 in the ER enhancing US2 mediated degradation
UL141 is a predominantly ER-resident viral protein which, in contrast to US2, does not actively
promote proteolysis of CD155 or TRAIL-R2 but sequesters them in the ER, thus preventing
their further trafficking through the secretory pathway [25, 26, 38]. We hypothesized that
UL141 might retain CD112 in the ER, and promote its transfer to US2 for TRC8-dependent
ubiquitination and subsequent degradation. Whereas UL141 or US2 alone caused only a partial
cell surface down-regulation of CD112 within the viral context (Fig 6D; Merlin ΔUS2–3.6x;
Merlin ΔUL141–2.8x), their combined action showed a more than additive effect (wt Merlin
-13.3x), suggesting synergy between the two immune evasion genes. Cooperativity was also ob-
served between TRC8 and UL141. Cell surface expression of CD112 was partially rescued by
TRC8 depletion of cells infected with wild-type HCMV or HCMVΔUL141, but not the
Fig 6. UL141 and US2 are both essential for surface down-regulation of CD112. (A,B) Scatter plots of proteins identified in PMP and quantified by 2 or
more unique peptides, for HFF infected with (A) HCMV wild-type vs. ΔUL141 and (B) HCMVwild-type vs. a ΔUL141ΔUS2 double deletion mutant. Fold
change (wild-type/specific gene deletion HCMV infected human fibroblasts) is shown as log2 ratio on the x axis and the summed peptide intensity on the y-
axis as log10. Proteins unaltered by HCMV UL141 or combined US2/UL141 gene deletion locate to the center of the plots (0-fold change), whereas proteins
left or right of center represent respectively proteins down- or up-regulated by HCMV in a UL141 (A) or combined US2/UL141-dependent (B) manner.
Significance B was used to estimate p values. (C) Schematic showing verified substrates of US2 and UL141. Substrates identified by PMP and confirmed by
us or previous studies are indicated. (D) HCMV downregulation of cell surface CD112 requires US2, UL141 and TRC8. Cell surface expression of CD112
was determined in HFF infected with mock or HCMVwild-type, ΔUS2 or ΔUL141 (moi 5) at 72 hours post infection. HFFs were stably transduced with
scrambled shRNA (HFF + shCtrl) (top panel) or shTRC8 (HFF + shTRC8) prior to HCMV infection (lower panel). Dotted lines indicate the mean CD112
expression in HFFs with control shRNA infected by indicated virus. See also S3 Table.
doi:10.1371/journal.ppat.1004811.g006
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HCMVΔUS2 deletion mutant (Fig 6C). TRC8-dependent downregulation of CD112 is thus
dependent on US2 within the viral context.
Two versions of CD112 are produced by differential splicing; the short α and long δ variants
can be distinguished using antibodies specific for their cytosolic tails [39] (S4 Fig). Following
wild-type HCMV infection, both CD112 α and δ forms were degraded (Fig 7A, lane 3 vs. lane
1). However, TRC8 depletion, or the absence of US2 (HCMV ΔUS2), rescued the CD112 δ
form in both its mature Endo H resistant form (Fig 7A, CD112 δ blots, lane 11 vs. 12 and 11
vs. 13, upper bands) and its immature, ER resident, Endo H sensitive forms (lower bands). A
similar pattern was seen with the CD112 α isoform, which was degraded by wild-type HCMV
and restored specifically in its immature form by a HCMV US2 deletion mutant or TRC8 de-
pletion (Fig 7A CD112 α blots, lane 3 vs. 4 and 3 vs. 5). The mature form of both the α and δ
isoform was only fully restored upon combined UL141 deletion (HCMV ΔUL141) and TRC8
depletion (Fig 7A lane 3 vs. 8 and 11 vs. 16). Therefore, the ability of UL141 to retain both
CD112 isoforms in the ER was only revealed in the absence of US2 or following TRC8 deple-
tion which abrogates US2-induced CD112 degradation. In contrast, CD155 downmodulation
Fig 7. UL141 retains CD112 in the ER and enhances US2mediated degradation. ER retention of CD112 is mediated by UL141 and only detected upon
depletion of US2 or TRC8. (A) HFF infected with mock, HCMV wild-type, ΔUS2 or ΔUL141 (moi 5) were analyzed for the indicated proteins at 72 hours post
infection, in the presence (shTRC8+) or absence (shTRC8-) of TRC8 depletion. (B) UL141 retains CD112 in the ER prior to TRC8-dependent degradation by
US2. THP-1 cells stably expressing US2, US11, UL141-Myc or shTRC8 were solubilized in 1% digitonin, immunoprecipitated with anti-Myc antibody and the
indicated proteins visualized by immunoblot. See also S4 Fig.
doi:10.1371/journal.ppat.1004811.g007
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was solely dependent on UL141 for retention in the ER, and integrin α4 required only US2 in
order to be degraded during virus infection (Fig 7A, CD155 and integrin α4 blots).
Together the data indicate that US2 and UL141 co-operate to prevent CD112 cell surface ex-
pression. Indeed UL141 and US2 appear capable of interacting, as evidenced by US2 co-immu-
noprecipitation with UL141 (Fig 7B, lane 8). UL141 also directly associated with its substrate
CD112 (Fig 7B, lane 7). This interaction is lost in the presence of US2 due to CD112 degrada-
tion, but was rescued following TRC8 depletion (Fig 7B, lanes 8 and 9). UL141 co-precipitated
US2 in both the presence and absence of TRC8 indicating UL141 itself is not degraded by US2
(Fig 7B, lanes 8 and 9). The control viral protein US11 is not found in association with UL141.
Collectively our results provide a remarkable example of cooperativity between two unrelated
viral proteins with diverse functions.
While the retention of CD112 in the ER by UL141 is inefficient and can easily be overcome,
teaming up with US2 promoted CD112 degradation via the TRC8-dependent pathway and
provides an efficient mechanism of controlling expression of this cellular protein.
Discussion
This study demonstrates the power of Plasma Membrane Profiling (PMP) as an unbiased ap-
proach to establish a global picture of how individual viral genes modulate the cell surface pro-
teome. Specific antibodies have traditionally been used to determine the changes in cell surface
proteins upon viral infection. This straightforward approach has proven particularly useful in
tracking changes in expression of critical immune effector cell ligands (e.g. MHC-I) during the
course of an infection. By design, this candidate approach is inevitably selective and cannot,
therefore, provide a complete picture of the effect of virus-encoded immunomodulatory func-
tions on the cell. By deploying PMP we were able to demonstrate the precision with which
US3, US6 and US11 specifically target MHCmolecules, whereas US2 was revealed to be a pleo-
tropic modulator of cell surface receptors whose function extends beyond T cell evasion to im-
pact on NK cell function, cell adhesion, signaling and coagulation (Fig 8).
We identified many novel cellular substrates that require US2 for their downregulation. For
all targets examined, US2-mediated degradation was dependent on the TRC8 E3 ligase, indicat-
ing that HCMV-mediated appropriation of this cellular ubiquitin ligase provides a common
pathway for the ER-associated degradation of US2 substrates. While US2 alone is sufficient for
the downregulation of the majority of new targets, effective removal of the NK cell ligand
CD112 requires co-operation between UL141, to retain CD112 in the ER, and US2 to initiate
CD112 degradation. The recruitment of US2 by UL141 greatly enhances the efficiency with
which CD112 is downregulated and the US2-dependant degradative pathway provides a poten-
tial conduit by which host proteins retained in the ER can be targeted for degradation, and may
be exploited by other HCMV proteins. US3, like UL141, retains MHCmolecules in the ER
from where they are degraded by the US2/TRC8 complex [17, 18]. Whereas US3 is an HCMV
immediate early gene with expression peaking at 8 hours post-infection [40], UL141 reaches
maximum expression at 4–5 days post-infection [26], suggesting US2 might change substrate
specificity during the HCMV life cycle. Reliance on different viral retention factors might
therefore enhance the flexibility of the US2/TRC8 degradation hub which may therefore be
customized towards specific requirements at different stages of the viral life cycle. Antigen pre-
sentation may be an acute problem early in viral infection, requiring US3, while NK cell killing,
and the requirement for UL141, becomes critical as MHC-I levels on the cell surface decline.
While the US2/TRC8 hub induces degradation of the UL141-substrate CD112, this mecha-
nism is not deployed against UL141’s other targets: CD155 and TRAIL-R2 [26]. Since these
three main cellular targets of UL141 are all implicated in distinct intracellular signaling
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pathways, there may be additional benefit to the virus in retaining CD155 and TRAIL-R2 in an
intracellular compartment while targeting CD112 to the proteasome. Alternatively binding to
CD155 and/or TRAIL-R2 might be incompatible with US2 binding to UL141. Recent structural
analysis suggests the Ig-like domain of UL141 is a structural mimic of TIGIT thus allowing
CD155 binding [41], whereas the interaction between UL141 and TRAIL-R2 involves a separate,
non-canonical death receptor interaction site. [42]. As it is unusual for an immunomodulator to
selectively target multiple unrelated receptors, further understanding of UL141 function may
highlight important aspects of the evolution of immune recognition and modulation. It will be of
particular interest to gain further structural insight into the CD112-UL141-US2 complex.
The largest group of novel targets downregulated by US2 were the integrins, a large family
of 18 α and 8 β chains that assemble into 24 different heterodimers. HCMV-induced integrin
down-regulation was first reported for integrin α1β1 [43], and we here show that US2 down-
regulates a variety of integrins including α1, α2, α4, α5, α6, α7, β1 and β4. αβ-heterodimer as-
sembly is a prerequisite for integrin maturation and transport to the cell surface [44–46]. Our
data suggest that α integrins are targeted by US2 for TRC8-induced ubiquitination and protea-
somal degradation, whereas the β1 subunit is retained in the ER due to the absence of its α
integrin binding partner. Whether each α chain is individually recognized by US2 and degrad-
ed, or US2 binds the shared β1 integrin, which is itself protected, but leads to the degradation
of any associated α chain, remains unclear. Our preliminary experiments favour the former
Fig 8. Model for US2 action in HCMV-infected cells. US2 targets a wide variety of novel cell surface
substrates, including integrins, the NK cell ligand CD112, the anti-coagulation factor thrombomodulin and the
IL-12 receptor β 1. The majority of these targets are directly targeted for proteasomal degradation in a TRC8
E3 ligase dependent pathway. β1 integrin is not itself degraded, but accumulates in an ER-resident immature
form following US2-induced degradation of its α integrin interaction partner. CD112 is retained in the ER by
UL141 from where US2 promotes the TRC8-dependent degradation. The functional consequences of US2
substrate degradation include diminished cell adhesion, migration, NK cell activation and
antigen presentation.
doi:10.1371/journal.ppat.1004811.g008
HCMVUS2 Regulates Multiple Cell Surface Proteins
PLOS Pathogens | DOI:10.1371/journal.ppat.1004811 April 14, 2015 14 / 24
scenario, as alpha chains were still degraded in cells depleted of β1 integrin, suggesting that
alpha chains are indeed direct targets of US2. However, we cannot exclude that, despite an ef-
fective depletion, any remaining β1 integrin, might still target alpha chains for degradation.
Furthermore, no common motif in α integrins targeted by US2 has been identified. It is even
less clear how US2 recognizes the broad range of substrates (MHC-I, integrins, thrombomodu-
lin, the IL-12 receptor β1 subunit) that share no apparent structural features.
Integrins mediate cellular attachment to a wide range of extracellular proteins, and control
multiple cellular functions, including morphology, migration and differentiation [47]. US2-in-
duced α integrin degradation is predicted to have a broad impact on the physiology of HCMV
infected cells. In this perspective integrin α6 is of interest as it is induced following HCMV in-
fection and concomitantly downregulated by US2, a pattern reminiscent of antiviral proteins.
Indeed, integrin α6 is essential for dendritic cell (DC) migration across the laminin and colla-
gen IV rich basement membranes to reach the draining lymph node for antigen presentation
[48, 49]. Integrin α6 specific blocking antibodies inhibit DC migration to lymph nodes [48],
and US2-induced integrin degradation should therefore counteract infection-induced DC mi-
gration. This might be particularly relevant during viral reactivation from latency when the im-
mune system is already primed to eradicate early stage infection. Additional US2-targetted
integrins may also inhibit DC migration: integrin α1 and α2 are receptors for the basement
membrane component collagen IV, while integrin α4 and α5 are likely required for DC reverse
migration across the endothelial cell layer into the lymph [50]. Furthermore, the α4 integrin is
essential for leukocyte transendothelial migration from blood into peripheral tissue and plays a
prominent role in immune surveillance [47]. Indeed a monoclonal antibody targeting α4β1
and α4β7 is in clinical use for the treatment of autoimmune diseases, and reduces inflamma-
tion by preventing leukocyte extravasation into the tissue [51, 52]. The downregulation of α4β1
by US2 may thus prevent circulating virus-infected myeloid cells from responding to chemoat-
tractants and homing.
Cell migration remains an understudied area of viral immune evasion. A global comparison
of plasma membrane proteins altered upon HCMV infection showed that cell surface proteins
involved in adhesion and migration are a major target for HCMV [30], and additional HCMV
genes likely contribute to HCMV’s modulation of cell migration. In addition to integrins,
downregulation of VCAM-1, at least eight protocadherins, five plexins and two ephrins was
seen [30]. Furthermore, the actin cytoskeleton of HCMV-infected cells is heavily reorganized
by UL135 which hijacks the WAVE2 complex and prevents the formation of focal adhesions
[53]. Furthermore, in latent HCMV infection, UL138 likely inhibits DC migration via degrada-
tion of the multidrug transporter MRP1 which is essential for leukotriene C4 (LTC4) secretion
[29, 54].
Although of potential benefit to viral immune evasion, US2-mediated degradation of cell
surface receptors could also potentially contribute to the pathophysiology associated with con-
genital HCMV infection. Several integrins targeted by US2 (α1, α4, α5, α6 and β1) are required
for placentation or fetal development [47]. Integrin α4 deficiency for example is embryonically
lethal in mice due to cardiac defects and defective placentation [55]. Depending on the cell
types infected in pregnancy, US2’s ability to downregulate integrin family members could con-
tribute to the fetal damage associated with HCMV infection. Indeed, HCMV-induced downre-
gulation of integrin α1β1 has been associated with impaired cytotrophoblast invasion and
placentation [56].
The endothelial cell surface protein thrombomodulin (THBD) is another US2 substrate that
might contribute to HCMV-associated fetal defects. THBD alters thrombin’s substrate specific-
ity from pro-coagulant and pro-inflammatory to anti-coagulant and anti-inflammatory [57]
and its deficiency leads to lethal consumptive coagulopathy in embryonic blood vessel
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endothelium. Since, the endothelium is a common site of HCMV infection in vivo, US2-in-
duced THBD degradation may contribute to both the coagulopathy and severe fetal thrombotic
vasculopathy seen in congenital HCMV infection. THBD is also a marker for a human DC sub-
set proficient in antigen cross-presentation, with similarities to mouse CD8+ DCs [58, 59].
While the exact role of THBD in these DCs is unknown, THBD regulates substrate affinity of
the TLR4 co-receptor CD14 [60], suggesting a potential broader role in antiviral immunity,
which may explain its induction in HCMV-infected cells and concomitant downregulation by
US2.
Our study emphasizes the key role of US2 in combating different HCMV host defense path-
ways through the downregulation of multiple cell surface receptors. As we are particularly in-
terested in HCMV evasion of the cellular immune response, this study focused on plasma
membrane proteins. Additional US2 substrates may yet be identified by analysis of ER-resident
proteins. Indeed, as shown for UL141, other viral proteins which retain host receptors in the
ER may also cooperate with US2 to degrade their cargo through the common pathway of
TRC8-dependent degradation.
Materials and Methods
Cell culture
THP-1 cells and HFF cells (System Bioscience) were grown in RPMI-1640 or DMEM respec-
tively (PAA), with 10% heat-inactivated fetal bovine serum (FCS; PAA) and penicillin/strepto-
mycin (pen/strep, Sigma).
HCMV viruses and infections
The HCMV strain Merlin is designated the reference HCMV genome sequence by the National
Center for Biotechnology Information [61] and is available as a BAC clone [62]. Merlin BAC
derived clone Merlin wild-type used for this study contains point mutations in RL13 and
UL128, enhancing replication in fibroblasts [62]. Generation of virus recombinants and stocks
was described previously [62]. All recombinants were validated by whole genome Illumina se-
quencing (S4 Table). Merlin ΔUS2 has a deletion of the US2 ORF; Merlin ΔUL141 has dele-
tions of the UL141 ORF; GFP tagged Merlin ΔUL16,18 ΔUS1-11 has deletions of the UL16,
UL18, US1-11 ORFs and contains a UL32-GFP fusion; GFP tagged Merlin ΔUL16,18 (Merlin
delta UL16/UL18, UL32-GFP) was described previously [25]. HFF cells were infected with
HCMV at indicated MOI for 72h.
The GFP-tagged endothelial-tropic HCMV TB40 strain was originally created by Christian
Sinzger (University of Ulm, Germany) [37] and a kind gift from Mark Wills (University of
Cambridge, UK). It contains an intact US1-11 region and a UL32-GFP fusion. For THP-1 in-
fections, THP-1 cells were starved for 12-16h in RPMI with 2% FCS, activated for 48h with
100ng/ml PMA (Sigma) and infected with TB40 at MOI 25. This resulted in infection of>95%
of cells as estimated by GFP positivity and MHC-I down-regulation. Infected cells were har-
vested at 96h post-infection.
Plasmids, lentivirus propagation and transduction
A C-terminal myc-tagged UL141 (HCMVMerlin strain) and HA-tagged human integrin α4
were cloned into the pHRSIN lentivirus vector with a hygromycin B selection cassette. Un-
tagged US2, US2 with a deletion of the C-terminal cytoplasmic tail (aa1-186; US2ΔC'), US3,
US6 and US11 were cloned into a pHRSIN lentivirus vector with an IRES CFP and puromycin
selection cassette. N-terminal HA-tagged US2 (HA-US2) was cloned into pHRSIN with a
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puromycin cassette only. The pHRSIN lentivirus expression system was used as described pre-
viously [63].
For shRNA-mediated knockdown of TRC8 and integrin β1 expression, hairpin oligonucleo-
tides were designed as described [13, 64], annealed, cloned into the pHR-SIREN lentiviral vec-
tor (a gift from Greg Towers, UCL, London). Lentivirus was produced as previously described
in 293ET cells and used to transduce THP-1 cells.
Antibodies and reagents
Primary antibodies used for flow cytometry were: mouse α-conformational MHC-I (W6/32),
mouse α-conformational HLA-A2 (BB7.2), mouse α-integrin β1 (Biolegend), mouse α-integrin
α1, (BD), mouse α-integrin α2, (BD), mouse α-integrin α4 (BD), rat α-integrin α6 (Biolegend),
rabbit α-integrin αV (Santa Cruz), mouse α-thrombomodulin (BD), mouse α-PTPRJ (Medical
& Biological Laboratories), mouse α-IL12 receptor β1 (BD), mouse α-CD112 (Santa Cruz),
mouse α-CD155 (Abcam) and FITC-conjugated mouse α-transferrin receptor (CD71; BD).
AlexaFluor 647 conjugated goat anti-mouse (Life Biosciences) was used as a secondary anti-
body. Antibodies used for immunoblotting were: mouse α-MHC-I (HC10), rabbit α-calreticu-
lin (Thermo), mouse α-β-actin (Sigma), mouse α-HA (Sigma), rabbit α-integrin α 4, α 5, β1,
β3 (Integrin antibody sampler kit; Cell Signaling), rabbit α-Integrin α6 (Cell Signaling), goat α-
CD112 (R&D Systems), rabbit α- CD112 δ form (Abcam), rabbit α-CD112 α form (LifeSpan
Biosciences), mouse α-CD155 [26], mouse α-HCMV IE antigen (Argene), mouse α-HCMV
US2 (a kind gift from Jack R. Bennink, NIH, US), rabbit α-HCMV US11 (a kind gift from Em-
manuel Wiertz, University of Utrecht, Netherlands), mouse α-HCMV UL141 [26], mouse α-
paxillin (BD) and rabbit α-phospho-paxillin Tyr118 (Cell Signaling). Antibodies used for im-
mune precipitation were: mouse α–HA and α-myc agarose affinity gel (Sigma), mouse α-integ-
rin β1 (Biolegend) and mouse α-ubiquitin (FK1; Millipore) in combination with protein A or
protein G-conjugated sepharose (Sigma).
siRNA
For siRNA gene depletion, cells were transfected using Oligofectamine (Invitrogen) at a final
concentration of 40 nM and harvested at 96 h post transfection. The following siRNA oligonu-
cleotides were used (Dharmacon, ON-TARGET PLUS):
CD112 siRNA-1, 5’-GCGCUGAGCAGGUCAUCUU-3’;
CD112 siRNA-2, 5’-GCAUGAGAGCUUCGAGGAA-3’.
Immunoblotting and immunoprecipitation
For immunoblots, cells were lysed in TBS (pH7.4) with 1% NP40, 0.1% SDS, 5mM IAA,
0.5mM PMSF (Sigma) and 1X complete protease inhibitor (Roche) for 30 min on ice. For im-
munoprecipitations, cells were lysed in 1% digitonin (Calbiochem) in TBS with 5mM IAA,
0.5mM PMSF (Sigma) and 1X complete protease inhibitor (Roche) for 30 min on ice. Lysates
were cleared of cellular debris by centrifugation and pre-cleared using IgG-sepharose (GE
Healthcare). Individual proteins were immunoprecipitated using indicated antibodies in com-
bination with Protein A or G sepharose (Sigma), washed extensively and eluted in SDS reduc-
ing sample buffer. All samples were heated for 10 min at 50°C, separated by SDS/PAGE and
transferred to PVDF membranes (Millipore). Membranes were probed with the indicated anti-
bodies, and reactive bands were visualized with Supersignal West Pico or West Dura (Thermo
Fisher Scientific).
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Metabolic labeling and pulse–chase
Cells were starved for 20 min in methionine-free, cysteine-free medium (Sigma), labeled with
[35S]methionine/[35S]cysteine (Amersham) for the indicated time and then chased in medium
containing an excess of cold methionine and cysteine (Sigma) at 37°C. Samples taken at the in-
dicated time points were lysed in 1% Triton X-100/TBS with 5mM IAA, 0.5mM PMSF (Sigma)
and 1X complete protease inhibitor (Roche) for 30 min on ice. Immunoprecipitations were
performed as above.
For visualization of ubiquitinated integrin α4, primary α-HA immune precipitations
from 35S-labelled cells were eluted at 50oC for 15min in 50μl TBS, containing 1% SDS. Elu-
ates were taken off the beads and after addition of 20μMDTT fully denatured at 70oC for
10min to dissociate interacting proteins. SDS was quenched by the addition of 1ml 1% Tri-
ton X-100/TBS with IAA/PMSF/protease inhibitor followed by secondary α-HA or α-ubi-
quitin immune precipitation.
Cell adhesion and migration assays
For cell adhesion assays, 96-well tissue culture plates were coated with 20 μg/ml fibronectin
(Sigma), 20 μg/ml recombinant VCAM1/Fc (R&D Biosystems) or 200ug/ml collagen (Sigma)
in PBS, for 16 h at 4°C and blocked with 0.5% bovine serum albumin (BSA) in PBS for 2 h at
37°C to block nonspecific binding. THP-1 cells expressing single HCMV genes were starved
3 h in serum free RPMI prior to assays, seeded on fibronectin-coated and uncoated plates for
1 h at 37°C and washed 3 times with PBS. Adherent cells numbers were quantified by
CyQUANT-NF (Invitrogen) according to the manufacturer’s protocol.
HCMV TB40 infected THP-1 cells were harvested at 96h post-infection using enzyme-free
cell dissociation buffer (Life Biosciences), counted and re-seeded on fibronectin, VCAM1, col-
lagen or uncoated plates. Following 1 h (fibronectin, VCAM1, uncoated) or 2 h incubation at
37°C, wells were washed 5 times with PBS, containing 0.5% BSA. Adherent cell numbers were
quantified as above.
For cell migration assays, Costar Transwell 24-well plates with 8 μm pore size (Thermo)
were coated with 20 μg/ml fibronectin (Sigma) in PBS, for 16 h at 4°C. Cell migration was per-
formed in RPMI with or without the chemotaxis agent MCP-1 (Sigma) at 10 ng/ml and 10%
FBS in the lower chamber. After 6 h incubation at 37°C, cells migrated to the lower chamber
were counted using a Neubauer counting chamber. All cell adhesion and migration assays were
performed in triplicate and p-values were calculated using paired Student’s t-test based on
independent experiments.
Plasma membrane profiling
Plasma membrane profiling was performed as described previously for THP-1 cells, with
minor modifications for adherent HFFs [28, 29]. Briefly, for THP-1 cells, 1.5 × 108 of each
SILAC-labeled cell type were pooled in a 1:1 ratio. Labeling was as follows: (first experiment,
Fig 1A, top left and bottom right panel) THP-control (light label); THP-US2 (medium label);
THP-US11 (heavy label). (Second experiment, Fig 1A, top right and bottom left panel)
THP-US6 (light label); THP-control (medium label); THP-US3 (heavy label). Surface sialic
acid residues were oxidized with sodium meta-periodate (Thermo) then biotinylated with ami-
nooxy-biotin (Biotium). The reaction was quenched, and the biotinylated cells incubated in a
1% Triton X-100 lysis buffer. Biotinylated glycoproteins were enriched with high affinity strep-
tavidin agarose beads (Pierce) and washed extensively. Captured protein was denatured with
DTT, alkylated with iodoacetamide (IAA, Sigma) and digested with trypsin (Promega) on-
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bead overnight. Tryptic peptides were collected and fractionated (described below). Glycopep-
tides were eluted using PNGase (New England Biolabs) then desalted using StageTips [65].
For HFF cells, one 150cm2 flask of HCMV-infected HFFFs per condition was washed twice
with ice-cold PBS. Labeling was as follows: (first experiment, Fig 4A) HFF/Merlin-wt (light
label), HFF-Merlin ΔUS2 (medium label). (Second experiment, Fig 6A) HFF/Merlin-wt (medi-
um label), HFF-Merlin ΔUL141 (heavy label). (third experiment, Fig 6B) HFF/Merlin-wt
(light label), HFF-Merlin ΔUL141ΔUS2 (medium label). Sialic acid residues were oxidized with
sodium meta-periodate (Thermo) then biotinylated with aminooxy-biotin (Biotium). The re-
action was quenched, and the biotinylated cells scraped into 1% Triton X-100 lysis buffer. Bio-
tinylated glycoproteins were enriched and digested as described above.
High pH reverse-phase high pressure liquid chromatography
(HpRP-HPLC) fractionation and mass spectrometric analysis
HpRP-HPLC was performed on tryptic peptides as described previously [28]. 90% of each tryp-
tic peptide sample was subjected to HpRP-HPLC fractionation using a Dionex Ultimate 3000
powered by an ICS-3000 SP pump with an Agilent ZORBAX Extend-C18 column (4.6 mm x
250 mm, 5 μm particle size). Peptides were resolved using a linear 40 min 0.1%-40% acetonitrile
gradient at pH 10.5. Eluting peptides were collected in 15s fractions. For THP-1 experiments, a
total of 30 combined fractions were generated then dried using an Eppendorf Concentrator for
LC-MSMS using a NanoAcquity uPLC (Waters, MA, USA) coupled to an LTQ-OrbiTrap XL
(Thermo, FL, UA). MS data was acquired between 300 and 2000 m/z at 60,000 fwhm with CID
spectra acquired in the LTQ with MSMS switching operating in a top 6 DDA fashion. Fraction-
ated HFF experiments were re-combined to give either 40 or 10 fractions. The 40 fraction experi-
ments were acquired using the OrbiTrap XL as above. The 10 fraction experiments were
acquired using a Q Exactive (Thermo) coupled to a RSLC nano3000 (Thermo) with MS data ac-
quired between 400 and 1650 m/z at 75,000 fwhm with HCD fragment spectra acquired in a top
10 DDA fashion.
Database searching and data processing
RawMS files were processed using MaxQuant version 1.3.0.5. [66, 67]. Data were searched
against concatenated Uniprot human and HCMV databases, and common contaminants [67].
Fragment ion tolerance was set to 0.5 Da with a maximum of 2 missed tryptic cleavage sites.
Carbamidomethyl cysteine was defined as a fixed modification, oxidised methionine, N-termi-
nal acetylation and deamidation (NQ) were selected as variable modifications. Reversed decoy
databases were used and the false discovery rate for both peptides and proteins were set at 0.01.
Protein quantitation utilised razor and unique peptides and required a minimum of 2 ratio
counts and normalized protein ratios reported. Peptide re-quantify was enabled in all analyses.
Summed intensity represents the sum of all heavy and light labelled peptide intensities for a
given protein and was calculated by MaxQuant [68]. Significance B values were calculated and
Gene Ontology Cellular Compartment (GOCC) terms added using Perseus version 1.2.0.16
(downloaded from http://maxquant.org). Significance B identifies the significance of outlier
protein ratios from the distribution of all ratios with a greater significance given to proteins
with a high intensity [68]. Ratios were excluded for proteins identified by<2 unique peptides,
or with a variability>150%. We assessed the number of PM proteins identified as described
previously [28].
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Supporting Information
S1 Fig. US2 but not US11 downregulates integrins α1, α 2, α 4, and β1, thrombomodulin,
PTPRJ and IL12 receptor β1, related to Fig 1. Cytofluorometric analysis of THP-1 cells,
transduced as indicated. Staining for transferrin receptor and integrin αV was included to
show the specificity of US2-induced immune receptor down-regulation.
(TIF)
S2 Fig. TRC8 knock-down rescues US2-induced integrin degradation, related to Fig 1.
THP-1 cells stably expressing US2 in combination with a control shRNA (shCtrl) or shRNA
against TRC8 (shTRC8) were analyzed by immunoblot with the indicated antibodies.
(TIF)
S3 Fig. US2 also downregulates integrin α4 and α6 in HFF cells in a TRC8 dependent man-
ner, related to Fig 2.HFF cells stably expressing an empty vector, US2, or US2 with a shRNA
against TRC8 (shTRC8) were analyzed by immunoblot with the indicated antibodies.
(TIF)
S4 Fig. CD112, α (short form) and δ (long form), could be distinguished by variant specific
antibodies, related to Fig 6.HFF cells transfected with two different siRNA against CD112
were analyzed by immunoblot with the indicated antibodies.
(TIF)
S1 Table. Cell surface proteome changes in THP-1 cells stably expressing US2 or US11,
compared to control cells, related to Fig 1.
(XLSX)
S2 Table. US2 downregulates cell surface integrins and MHC-I.
(XLSX)
S3 Table. Cell surface proteome changes in HFF infected with wild-type or deletion strains
of HCMV, related to Figs 4 and 5.
(XLSX)
S4 Table. Gene bank entries of HCMV whole genome-sequencing and primers used to cre-
ate deletion viruses.
(DOCX)
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